A composite intronic element directs dynamic binding of the progesterone receptor and GATA-2

Molecular Endocrinology

Volumn 23, Issue 1, 2009, Pages 61-73

  Magklara, Angeliki ^a   Smith, Catharine L ^a,b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; DNA; FK 506 BINDING PROTEIN; FK 506 BINDING PROTEIN 5; GESTAGEN; PROGESTERONE RECEPTOR; RNA POLYMERASE II; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING KINETICS; BINDING SITE; BREAST; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; INTRON; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BINDING SITES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA, NEOPLASM; FEMALE; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HELA CELLS; HUMANS; INTRONS; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; PROMEGESTONE; RECEPTORS, PROGESTERONE; RECOMBINANT PROTEINS; TACROLIMUS BINDING PROTEINS;

MOUSE MAMMARY TUMOR VIRUS;

EID: 58149263382     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2008-0028     Document Type: Article

References (61)

1. Graham JD, Clarke CL 1997 Physiological action of progesterone in target tissues. Endocr Rev 18:502-519
2. Ismail PM, Amato P, Soyal SM, DeMayo FJ, Conneely OM, O'Malley BW, Lydon JP 2003 Progesterone involvement in breast development and tumorigenesis - as revealed by progesterone receptor "knockout" and "knockin" mouse models. Steroids 68:779-787
3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288:321-333
4. Ma Y, Katiyar P, Jones LP, Fan S, Zhang Y, Furth PA, Rosen EM 2006 The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells. Mol Endocrinol 20:14-34
5. Poole AJ, Li Y, Kim Y, Lin SC, Lee WH, Lee EY 2006 Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist. Science 314:1467-1470
6. Edwards DP 2000 The role of coactivators and corepressors in the biology and mechanism of action of steroid hormone receptors. J Mammary Gland Biol Neoplasia 5:307-324
7. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M 2006 Genome-wide analysis of estrogen receptor binding sites. Nat Genet 38:1289-1297
8. So AY, Chaivorapol C, Bolton EC, Li H, Yamamoto KR 2007 Determinants of cell- and gene-specific transcriptional regulation by the glucocorticoid receptor PLoS Genet 3:e94
9. Wang Q, Li W, Liu XS, Carroll JS, Janne OA, Keeton EK, Chinnaiyan AM, Pienta KJ, Brown M 2007 A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol Cell 27:380-392
10. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M 2002 Multiple control of interleukin-8 gene expression. J Leukoc Biol 72:847-855
11. Freund A, Jolivel V, Durand S, Kersual N, Chalbos D, Chavey C, Vignon F, Lazennec G 2004 Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 23:6105-6114
12. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M 2005 Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33-43
13. Kester HA, van der Leede BM, van der Saag PT, van der Burg B 1997 Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J Biol Chem 272:16637-16643
14. Richer JK, Jacobsen BM, Manning NG, Abel MG, Wolf DM, Horwitz KB 2002 Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells. J Biol Chem 277:5209-5218
15. Wan Y, Nordeen SK 2002 Overlapping but distinct gene regulation profiles by glucocorticoids and progestins in human breast cancer cells. Mol Endocrinol 16:1204-1214
16. Chavez S, Beato M 1997 Nucleosome-mediated synergism between transcription factors on the mouse mammary tumor virus promoter. Proc Natl Acad Sci USA 94:2885-2890
17. Fletcher TM, Ryu BW, Baumann CT, Warren BS, Fragoso G, John S, Hager GL 2000 Structure and dynamic properties of a glucocorticoid receptor-induced chromatin transition. Mol Cell Biol 20:6466-6475
18. Rayasam GV, Elbi C, Walker DA, Wolford R, Fletcher TM, Edwards DP, Hager GL 2005 Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro. Mol Cell Biol 25:2406-2418
19. Baughman G, Wiederrecht GJ, Campbell NF, Martin MM, Bourgeois S 1995 FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition. Mol Cell Biol 15:4395-4402
20. Nair SC, Rimerman RA, Toran EJ, Chen S, Prapapanich V, Butts RN, Smith DF 1997 Molecular cloning of human FKBP51 and comparisons of immunophilin interactions with Hsp90 and progesterone receptor. Mol Cell Biol 17:594-603
21. Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S, Lee D, Wang V, Leysens M, Higgins B, Martin J, Gerald W, Dracopoli N, Cordon-Cardo C, Scher HI, Hampton GM 2000 Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res 60:6134-6141
22. Hubler TR, Denny WB, Valentine DL, Cheung-Flynn J, Smith DF, Scammell JG 2003 The FK506-binding immunophilin FKBP51 is transcriptionally regulated by progestin and attenuates progestin responsiveness. Endocrinology 144:2380-2387
23. Shang Y, Hu X, DiRenzo J, Lazar MA, Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843-852
24. Kang Z, Pirskanen A, Janne OA, Palvimo JJ 2002 Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 277:48366-48371
25. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F 2003 Estrogen receptor-α directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751-763
26. Owen GI, Richer JK, Tung L, Takimoto G, Horwitz KB 1998 Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300. J Biol Chem 273:10696-10701
27. Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq C, Yamamoto KR 2004 Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci USA 101:15603-15608
28. Nordeen SK, Suh BJ, Kuhnel B, Hutchison CD 1990 Structural determinants of a glucocorticoid receptor recognition element. Mol Endocrinol 4:1866-1873
29. Stepanova M, Lin F, Lin VC 2006 Establishing a statistic model for recognition of steroid hormone response elements. Comput Biol Chem 30:339-347
30. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B 2004 JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32:D91-D94
31. Ko LJ, Engel JD 1993 DNA-binding specificities of the GATA transcription factor family. Mol Cell Biol 13:4011-4022
32. Schwartzbauer G, Schlesinger K, Evans T 1992 Interaction of the erythroid transcription factor cGATA-1 with a critical auto-regulatory element. Nucleic Acids Res 20:4429-4436
33. Takimoto GS, Tasset DM, Eppert AC, Horwitz KB 1992 Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299. Proc Natl Acad Sci USA 89:3050-3054
34. Lefebvre P, Berard DS, Cordingley MG, Hager GL 1991 Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines. Mol Cell Biol 11:2529-2537
35. Smith CL, Archer TK, Hamlin-Green G, Hager GL 1993 Newly expressed progesterone receptor cannot activate stable, replicated mouse mammary tumor virus templates but acquires transactivation potential upon continuous expression. Proc Natl Acad Sci USA 90:11202-11206
36. Yuan CX, Ito M, Fondell JD, Fu ZY, Roeder RG 1998 The TRAP220 component of a thyroid hormone receptor-associated protein (TRAP) coactivator complex interacts directly with nuclear receptors in a ligand-dependent fashion. Proc Natl Acad Sci USA 95:7939-7944
37. Gardiner-Garden M, Frommer M 1987 CpG islands in vertebrate genomes. J Mol Biol 196:261-282
38. Hubler TR, Scammell JG 2004 Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids. Cell Stress Chaperones 9:243-252
39. Magee JA, Chang LW, Stormo GD, Milbrandt J 2006 Direct, androgen receptor-mediated regulation of the FKBP5 gene via a distal enhancer element. Endocrinology 147:590-598
40. Tsai FY, Keller G, Kuo FC, Weiss M, Chen J, Rosenblatt M, Alt FW, Orkin SH 1994 An early haematopoietic defect in mice lacking the transcription factor GATA-2. Nature 371:221-226
41. Dorfman DM, Wilson DB, Bruns GA, Orkin SH 1992 Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. J Biol Chem 267:1279-1285
42. Jippo T, Mizuno H, Xu Z, Nomura S, Yamamoto M, Kitamura Y 1996 Abundant expression of transcription factor GATA-2 in proliferating but not in differentiated mast cells in tissues of mice: demonstration by in situ hybridization. Blood 87:993-998
43. Ma GT, Roth ME, Groskopf JC, Tsai FY, Orkin SH, Grosveld F, Engel JD, Linzer DI 1997 GATA-2 and GATA-3 regulate trophoblast-specific gene expression in vivo. Development 124:907-914
44. Umeoka K, Sanno N, Osamura RY, Teramoto A 2002 Expression of GATA-2 in human pituitary adenomas. Mod Pathol 15:11-17
45. Gordon DF, Tucker EA, Tundwal K, Hall H, Wood WM, Ridgway EC 2006 MED220/thyroid receptor-associated protein 220 functions as a transcriptional coactivator with Pit-1 and GATA-2 on the thyrotropin-β promoter in thyrotropes. Mol Endocrinol 20:1073-1089
46. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z 2006 GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127:1041-1055
47. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, Lindeman GJ, Visvader JE 2007 Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9:201-209
48. Hoch RV, Thompson DA, Baker RJ, Weigel RJ 1999 GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer 84:122-128
49. Parikh P, Palazzo JP, Rose LJ, Daskalakis C, Weigel RJ 2005 GATA-3 expression as a predictor of hormone response in breast cancer. J Am Coll Surg 200:705-710
50. Eeckhoute J, Keeton EK, Lupien M, Krum SA, Carroll JS, Brown M 2007 Positive cross-regulatory loop ties GATA-3 to estrogen receptor α expression in breast cancer. Cancer Res 67:6477-6483
51. Cirillo LA, Lin FR, Cuesta I, Friedman D, Jarnik M, Zaret KS 2002 Opening of compacted chromatin by early developmental transcription factors HNF3 (FoxA) and GATA-4. Mol Cell 9:279-289
52. Vakoc CR, Letting DL, Gheldof N, Sawado T, Bender MA, Groudine M, Weiss MJ, Dekker J, Blobel GA 2005 Proximity among distant regulatory elements at the β-globin locus requires GATA-1 and FOG-1. Mol Cell 17: 453-462
53. Spilianakis CG, Flavell RA 2004 Long-range intrachromosomal interactions in the T helper type 2 cytokine locus. Nat Immunol 5:1017-1027
54. Perissi V, Rosenfeld MG 2005 Controlling nuclear receptors: the circular logic of cofactor cycles. Nat Rev Mol Cell Biol 6:542-554
55. Rowan BG, O'Malley BW 2000 Progesterone receptor coactivators. Steroids 65:545-549
56. Smith CL, Wolford RG, O'Neill TB, Hager GL 2000 Characterization of transiently and constitutively expressed progesterone receptors: evidence for two functional states. Mol Endocrinol. 14:956-971
57. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T 2005 MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933-2942
58. Suzuki Y, Yamashita R, Sugano S, Nakai K 2004 DBTSS, DataBase of Transcriptional Start Sites: progress report 2004. Nucleic Acids Res 32:D78-D81
59. Takai D, Jones PA 2003 The CpG island searcher: a new WWW resource. In Silico Biol 3:235-240
60. Pan YF, Wansa KD, Liu MH, Zhao B, Hong SZ, Tan PY, Lim KS, Borque G, Liu ET, Cheung E 2008 Regulation of estrogen receptor-mediated long-range transcription via evolutionarily conserved distal response elements. J Biol Chem 283:32977-32988
61. Barnett DH, Sheng S, Charn TH, Waheed A, Sly WS, Lin CY, Liu ET, Katzenellenbogen BS 2008 Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res 68:3505-3515